Elorde, Reneboy .
HRN: 28-93-23 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2026
CEFTAZIDIME 1GM (VIAL)
04/30/2026
05/07/2026
IV
2G
Q8H
IMMUNOCOMPROMISED STATE, PNEUMONIA
Checking Initial Appropriateness
05/06/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/06/2026
05/13/2026
IV
750mg
Q24h
Febrile Neutropenia
Checking Initial Appropriateness
05/06/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/06/2026
05/13/2026
TIV
900mg
OD
Febrile Neutropenia
Checking Initial Appropriateness
05/06/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/06/2026
05/13/2026
TIV
400mg
OD
Immunocompromised State Pneumonia
Checking Initial Appropriateness
05/13/2026
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/13/2026
05/19/2026
IV
400mg
OD
Immunocompromised State Pneumonia
Checking Initial Appropriateness
05/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/13/2026
05/19/2026
IV
900mg
OD
Febrile Neutropenia
Checking Initial Appropriateness
05/13/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/13/2026
05/19/2026
IV
750mg
OD
Febrile Neutropenia
Checking Initial Appropriateness